Resources: Page 394

Low-dose MBI safe adjunct to screening mammo
By Kate Madden Yee
Tuesday, November 27 | 10:40 a.m.-10:50 a.m. | SSG01-02 | Arie Crown TheaterLow-dose molecular breast imaging (MBI) is a viable adjunct to screening mammography in women with dense breasts, according to Mayo Clinic researchers.
November 13, 2012
Adding DBT to mammography lowers recall rates
By Kate Madden Yee
Monday, November 26 | 3:30 p.m.-3:40 p.m. | SSE02-04 | Room E450AUsing digital breast tomosynthesis (DBT) as an adjunct to mammography lowers recall rates, according to this Monday afternoon scientific session.
November 13, 2012
DBT plus mammography equals increased cancer detection
By Kate Madden Yee
Monday, November 26 | 3:10 p.m.-3:20 p.m. | SSE02-02 | Room E450AAdding digital breast tomosynthesis (DBT) to mammography can increase the cancer detection rate from 1.5% to 2.3%, researchers from Spain have concluded.
November 13, 2012
Preop MRI lowers re-excision rates
By Kate Madden Yee
Monday, November 26 | 3:00 p.m.-3:10 p.m. | SSE01-01 | Arie Crown TheaterPreoperative MRI decreases re-excision rates, with no significant difference in mastectomy rates or cancer detection, according to a study to be presented on Monday afternoon by researchers from Emory University.
November 13, 2012
DBT reduces callbacks, boosts cancer detection
By Kate Madden Yee
Monday, November 26 | 12:45 p.m.-1:15 p.m. | LL-BRS-MO8B | Lakeside Learning CenterThe first five months of using digital breast tomosynthesis (DBT) in a screening practice showed a small reduction in the overall callback rate and a small increase in the cancer detection rate; however, these results were not statistically significant, according to researchers from the University of Pennsylvania.
November 13, 2012
Breast MRI reduces healthcare costs
By Kate Madden Yee
Monday, November 26 | 12:45 p.m.-1:15 p.m. | LL-BRS-MO3B | Lakeside Learning CenterCompared with x-ray and ultrasound, using breast MRI in women with dense breast tissue does add cost. But there's substantial overall savings when breast MRI is used, according to this poster presentation by German researchers.
November 13, 2012
What's the best way to track women with breast cancer history?
By Kate Madden Yee
Monday, November 26 | 12:15 p.m.-12:45 p.m. | LL-BRS-MO4A | Lakeside Learning CenterWomen with personal histories of breast cancer can return to screening breast exams 10 years after their initial cancer diagnosis due to low likelihood of recurring cancer after this follow-up period, according to a poster presentation to be given on Monday.
November 13, 2012
BSGI boosts breast cancer detection in women with dense tissue
By Kate Madden Yee
Monday, November 26 | 10:10 a.m.-10:20 a.m. | VSMI21-09 | Arie Crown TheaterWhen used in conjunction with mammography, breast-specific gamma imaging (BSGI) increases cancer detection by 2.5% in women with dense breast tissue, which is comparable to the 2.1% increase in detection reported for breast MRI, according to researchers from George Washington University.
November 13, 2012
US matches MRI in identifying lesions seen on BSGI
By Kate Madden Yee
Monday, November 26 | 10:00 a.m.-10:10 a.m. | VSMI21-08 | Arie Crown TheaterMore than 50% of lesions seen on breast-specific gamma imaging (BSGI) can also be visualized with targeted ultrasound -- a percentage comparable to MRI results, according to researchers from George Washington University.
November 13, 2012
US, MRI tumor measurements can predict residual disease
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-BRS-SU5A | Lakeside Learning CenterHow best can doctors assess residual disease in inflammatory breast cancer patients who have undergone neoadjuvant chemotherapy? Find out in this Sunday poster presentation.
November 13, 2012
Annual breast US benefits women with dense tissue
By Kate Madden Yee
Sunday, November 25 | 11:25 a.m.-11:35 a.m. | SSA01-05 | Arie Crown TheaterSince the 2009 passage of the breast density notification law in Connecticut, radiologists have a legal obligation to inform patients with mammographically dense breast tissue that they may benefit from the addition of screening breast ultrasound. But how effective is that second round of screening?
November 13, 2012
FDG-PET/CT works for primary breast cancer staging
By Kate Madden Yee
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA18-04 | Room S505ABFDG-PET/CT may be used as primary staging modality in patients with primary breast cancer, according to this Sunday morning presentation to be given by German researchers.
November 13, 2012
Previous Page
Page 394 of 725
Next Page